424 / | HD | DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS |
|
9.1 | DF | IN VIVO DIAGNOSIS OR IN VIVO TESTING {7} |
9.3 | | .~ Magnetic imaging agent (e.g., NMR, MRI, MRS, etc.) {7} |
9.31 | DF | .~.~> Clay or zeolite containing |
9.32 | DF | .~.~> Particle containing a transition, actinide, or lanthanide metal (e.g., hollow or solid particle, granule, etc.) {2} |
9.33 | DF | .~.~> Nitroxide or nitroxide containing |
9.34 | DF | .~.~> Polypeptide attached to or complexed with the agent (e.g., protein, antibody, etc.) {1} |
9.35 | DF | .~.~> Carbohydrate or derivative thereof attached to or complexed with the agent {1} |
9.36 | DF | .~.~> Transition, actinide, or lanthanide metal containing {2} |
9.37 | DF | .~.~> Imageable halogen containing |